BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 18959697)

  • 1. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP; Hayes AJ; Thomas JM
    ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inguinal and pelvic lymph node dissection for stage III melanoma.
    Hughes TM; Thomas JM
    Br J Surg; 1999 Dec; 86(12):1493-8. PubMed ID: 10594495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population.
    Spillane AJ; Haydu L; McMillan W; Stretch JR; Thompson JF
    Ann Surg Oncol; 2011 Sep; 18(9):2521-8. PubMed ID: 21556951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the node of Cloquet the sentinel node for the iliac/obturator node group?
    Shen P; Conforti AM; Essner R; Cochran AJ; Turner RR; Morton DL
    Cancer J; 2000; 6(2):93-7. PubMed ID: 11069226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
    Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
    Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
    J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined clearance of pelvic and superficial nodes for clinical groin melanoma.
    West CA; Saleh DB; Peach H
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1711-8. PubMed ID: 25219338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?
    Soteldo J; Ratto EL; Gandini S; Trifirò G; Mazzarol G; Tosti G; Rastrelli M; Verrecchia F; Baldini F; Testori A
    Melanoma Res; 2010 Apr; 20(2):133-7. PubMed ID: 20087232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both.
    Jonk A; Kroon BB; Rümke P; van der Esch EP; Hart AA
    Surg Gynecol Obstet; 1988 Jul; 167(1):28-32. PubMed ID: 3289133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma.
    Ali-Khan AS; Crundwell M; Stone C
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):1063-7. PubMed ID: 18487094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.